Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience

Low-risk myelodysplastic syndromes (LR-MDS) are a very heterogeneous disease, with extremely variable clinical features and outcome. Therapeutic strategies are still limited and mainly consist of erythropoiesis-stimulating agents (ESAs) and transfusion support. The contribution of molecular lesions...

Descripción completa

Detalles Bibliográficos
Autores principales: Fattizzo, Bruno, Levati, Giorgia Virginia, Giannotta, Juri Alessandro, Cassanello, Giulio, Cro, Lilla Marcella, Zaninoni, Anna, Barbieri, Marzia, Croci, Giorgio Alberto, Revelli, Nicoletta, Barcellini, Wilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980524/
https://www.ncbi.nlm.nih.gov/pubmed/35392224
http://dx.doi.org/10.3389/fonc.2022.795955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980524/
https://www.ncbi.nlm.nih.gov/pubmed/35392224
http://dx.doi.org/10.3389/fonc.2022.795955

Ejemplares similares